| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 08/27/2009 | US20090214438 Methods and compositions for the preparation and use of toxin conjugates |
| 08/27/2009 | US20090214437 In Vivo Mitochondrial Labeling Using Positively-Charged Nitroxide Enhanced and Gadolinium Chelate Enhanced Magnetic Resonance Imaging |
| 08/27/2009 | US20090214434 Method of detecting and treating allogenic cells responsible for endometriosis |
| 08/27/2009 | US20090214433 Hyperpolarized solid materials with long spin relaxation times for use as imaging agents in magnetic resonance imaging |
| 08/27/2009 | US20090214432 Radicals and Their Use As Paramagnetic Agents in a DNP Process |
| 08/27/2009 | US20090214431 Identification of ergothioneine transporter and therapeutic uses thereof |
| 08/27/2009 | US20090214430 Polypeptide specifically bound to phosphatidylserine and the use thereof |
| 08/27/2009 | US20090214429 Methods and compositions related to targeting tumors and wounds |
| 08/27/2009 | US20090214428 Human Monoclonal Antibodies Against Hendra and Nipah Viruses |
| 08/27/2009 | US20090214427 Novel peptides |
| 08/27/2009 | US20090214426 Assay Method |
| 08/27/2009 | US20090214425 Tumor therapy with replication competent sindbis viral vectors |
| 08/27/2009 | US20090214424 Human glycoprotein hormone superagonists and uses thereof |
| 08/27/2009 | US20090214419 Self-assembled biodegradable polymersomes |
| 08/27/2009 | CA2715747A1 B ring reduced-d ring oxidized tetrapyrollic photosensitizers for photodynamic therapy and tumor imaging |
| 08/27/2009 | CA2714118A1 Process for preparing a pharmaceutical formulation of contrast agents |
| 08/27/2009 | CA2713872A1 Methods and compositions related to peptides and proteins with c-terminal elements |
| 08/26/2009 | EP2091570A1 Contrast agents |
| 08/26/2009 | EP1332364B1 In vivo detection of biomolecule concentrations using fluorescent tags |
| 08/26/2009 | CN101516406A Method of optimizing the treatment of Philadelphia-positive leukemia with Abl tyrosine kinase inhibitors |
| 08/26/2009 | CN101516405A 荧光化学传感器 Fluorescent chemical sensor |
| 08/26/2009 | CN101513542A Method for preparing iodic liquid embolic agent capable of long-time self-developing |
| 08/26/2009 | CN101513534A Use of quantum dot in preparation of blood vessel injury testing reagent |
| 08/26/2009 | CN101513533A Method for building models of various diseases in one rat body and application thereof |
| 08/25/2009 | US7579515 Use of the present invention will enhance proper timing; if the switch increases ovulation >2.4-fold, oocyte production can be achieved even more efficiently, creating major benefits for the transgenic/cloning industry |
| 08/25/2009 | US7579324 Carrier, linker and nonantibiotic therapeutic agent; small molecules; bioavailability, efficacy |
| 08/25/2009 | US7579009 a whole cell of a bacterium from the genera Rhodococcus, Gordonia, Nocardia, Dietzia, Tsukamurella and Nocardioides and at least one antigen or antigenic determinant; tuberculosis and leishmaniasis; vaccines |
| 08/25/2009 | CA2215356C Novel embolizing compositions |
| 08/20/2009 | US20090209658 Embolic compositions |
| 08/20/2009 | US20090208422 Composition for improving efficiency of drug delivery |
| 08/20/2009 | US20090208421 Process for preparing a pharmaceutical formulation of contrast agents |
| 08/20/2009 | US20090208420 Iron oxide-binding peptides |
| 08/20/2009 | US20090208419 Multimodality Imaging of Reporter Gene Expression Using a Novel Fusion Vector in Living Cells and Animals |
| 08/20/2009 | US20090208418 Superantibody synthesis and use in detection, prevention and treatment of disease |
| 08/20/2009 | US20090208417 Detection and Localized Imaging of Cancer Using X-Ray Fluorescent Nanoparticle/Preferential Locator Conjugates |
| 08/20/2009 | US20090208416 Monoclonal antibodies against nkg2a |
| 08/20/2009 | US20090208415 Tropane compounds |
| 08/20/2009 | US20090208412 Contrast Agents |
| 08/20/2009 | US20090208411 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 08/20/2009 | US20090208409 Encapsulated nanoparticles for computed tomography imaging |
| 08/20/2009 | US20090208408 Use of vcam-1 ligands for detecting and/or treating cardiovascular diseases |
| 08/20/2009 | DE102008009541A1 Anorganisch-organischer Kompositleuchtstoff Inorganic-organic Kompositleuchtstoff |
| 08/20/2009 | DE102008005673A1 Bläschen, sowie Verfahren zur Herstellung und Manipulation von Bläschen Vesicles, and methods for preparing and manipulating bubbles |
| 08/19/2009 | EP2090322A1 Use of fsh receptor ligands for diagnosis and therapy of cancer |
| 08/19/2009 | EP2089362A1 Metal chelates having a perfluorinated peg group, method for the production thereof, and use thereof |
| 08/19/2009 | EP2089063A2 X-ray contrast agents comprising a metal chelate and a polyhalogenated phenol, thiophenol, resorcinol, thioresorcinol or dithioresorcinol |
| 08/19/2009 | EP2089062A2 Intranasal therapeutics for neuroprotection |
| 08/19/2009 | EP1881852B1 Mri contrast agents comprising cest active paramagnetic complex |
| 08/19/2009 | EP1827508B1 Targeting agents for molecular imaging |
| 08/19/2009 | EP1778858A4 High throughput pharmaceutical screening using drosophila |
| 08/19/2009 | EP1776139A4 Targeting damaged lung tissue |
| 08/19/2009 | EP1740225A4 Contrast agents for myocardial perfusion imaging |
| 08/19/2009 | EP1467772B1 Diagnostic conjugate useful for intracellular imaging and for differentiating between tumor and non-tumor cells |
| 08/19/2009 | CN101512007A Methods and compositions for use in treatment of patients with autoantibody positive diseases |
| 08/19/2009 | CN101511392A Nanogel contrast agents for optical molecular imaging |
| 08/19/2009 | CN101511389A Targeted imaging and/or therapy using the [3+2] azide-alkyne cycloaddition |
| 08/19/2009 | CN101511382A Selectively targeted antimicrobial peptides and the use thereof |
| 08/19/2009 | CN101511366A Methods and compositions for increasing patient tolerability during myocardial imaging methods |
| 08/19/2009 | CN101508970A Immune cell modification method and cell modification device |
| 08/19/2009 | CN100529054C Modulating production of pneumococcal capsular polysaccharide |
| 08/19/2009 | CN100528241C Vitamin-targeted imaging agents |
| 08/18/2009 | US7576184 Monoclonal antibody for use in detection of plant protein associated with natural rubber; diagnosing latex allergies and hypersensitivity |
| 08/18/2009 | US7576181 Method of administering porcine B-domainless fVIII |
| 08/18/2009 | US7576177 Heat shock proteins (HSP) activate lymphocytes to produce immunomodulatory cytokines and influence cytokines, chemokines, and surface antigens; drug screening |
| 08/18/2009 | US7575935 Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 08/18/2009 | US7575873 human monoclonal antibody fragment (Fab), cloned by phage display that binds specifically to oxidized forms of low density lipoproteins (OxLDL) and not native LDL; use of the antibody for methods of diagnosis and treatment of atherosclerosis |
| 08/13/2009 | WO2009100014A1 System for fluorinating organic compounds |
| 08/13/2009 | WO2009100011A2 Targeted cellular selectivity of surface active molecules |
| 08/13/2009 | WO2009098192A1 Mr imaging agent or medium compressing hzperpolarised 13c alanine and methods of imaging wherein such an imaging medium is used |
| 08/13/2009 | WO2009098191A2 Method to produce hyperpolarised amino acids and aminosulphonic acids |
| 08/13/2009 | WO2009097692A1 Biomarkers for head-and-neck cancers and precancers |
| 08/13/2009 | WO2009061456A3 Ultrasmall superparamagnetic iron oxide nanoparticles and uses thereof |
| 08/13/2009 | WO2009054958A3 Metallofullerene contrast agents |
| 08/13/2009 | WO2009045535A3 Fluorine-18 derivative of dasatinib and uses thereof |
| 08/13/2009 | WO2009000777A3 Imaging diagnostics by combining contrast agents |
| 08/13/2009 | WO2008140475A3 Imaging contrast agents using nanoparticles |
| 08/13/2009 | US20090203584 Peptide-based Compounds |
| 08/13/2009 | US20090202443 Methods of improving skin quality |
| 08/13/2009 | US20090202442 Enerceutical activation of the alternative cellular energy (ACE) pathway in therapy of diseases |
| 08/13/2009 | US20090202441 Compositions and methods to prevent cancer with cupredoxins |
| 08/13/2009 | US20090202439 Methods for treatment of angiogenesis |
| 08/13/2009 | US20090202438 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 08/13/2009 | US20090202437 Therapeutic Use of Lpi, a Staphylococcal Lectin Pathway Inhibitor in Inflammatory diseases |
| 08/13/2009 | US20090202435 Diagnostic compounds for targeting a chemokine receptors |
| 08/13/2009 | US20090202433 Methods and Compositions for Generating Bioactive Assemblies of Increased Complexity and Uses |
| 08/13/2009 | US20090202432 Treatment and prophylaxis of amyloidosis |
| 08/13/2009 | US20090202429 Methods for testing anti-thrombotic agents |
| 08/13/2009 | DE102008013620A1 Knochenzementmischung zur Herstellung eines MRT-signalgebenden Knochenzements Bone cement mixture for producing an MRI signaling bone cement |
| 08/13/2009 | CA2713850A1 Biomarkers for head-and-neck cancers and precancers |
| 08/12/2009 | EP2087152A1 Endometrial biomarkers |
| 08/12/2009 | EP2086592A2 Weakly basic 2- nitroimidazoles for the non-invasive detection of tissue hypoxia |
| 08/12/2009 | EP2086404A1 Method for managing patients with cancers |
| 08/12/2009 | EP1525478B1 Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3-expressing tumors |
| 08/12/2009 | EP1434768B1 Enhanced substrate imaging by reversible binding to a paramagnetic complex |
| 08/12/2009 | EP1149111B1 Method and composition for angiogenesis inhibition |
| 08/12/2009 | CN201286698Y Elastic vertical compression type pain-sense quantitative measurement device |
| 08/12/2009 | CN101506179A Method of dynamic nuclear polarisation (DNP) and compounds and compositions for use in the method |
| 08/12/2009 | CN101505802A Imaging medium comprising lactate and hyperpolarised 13C-pyruvate |
| 08/12/2009 | CN101505801A Contrast agent comprising a TM2+ containing luminescent substance for optical imaging |
| 08/12/2009 | CN101505714A Use of a composition for skin treatment under x-irradiation |